29.12.2017 – 17:45

Zur Rose AG

EQS-News: Zur Rose Group: Takeover of Eurapon and Vitalsana successfully concluded

EQS Group-News: Zur Rose Group AG / Key word(s): Takeover
Zur Rose Group: Takeover of Eurapon and Vitalsana successfully concluded

29.12.2017 / 17:35

--------------------------------------------------------------------------------
Press release

Zur Rose Group: Takeover of Eurapon and Vitalsana successfully concluded

Following approval by the competition authorities, the Zur Rose Group has
successfully completed the takeover of Eurapon and Vitalsana. In the course of
these transactions, the company acquired Eurapon Pharmahandel GmbH in Bremen
(Germany), as well as the mail-order pharmacy Vitalsana B.V. in Heerlen
(Netherlands) and the associated service provider ApDG GmbH in Ulm (Germany).

Contact
Pascale Ineichen, Communications Manager
e-mail:  pascale.ineichen@zurrose.com, telephone: +41 52 724 08 18

Zur Rose Group
Operating under the "Zur Rose" and "DocMorris" brands, the Swiss-based Zur Rose
Group is Europe's largest online pharmacy and one of Switzerland's leading
wholesale suppliers to medical doctors. Through its business model, it helps to
ensure safe, reliable and high-quality pharmaceutical care, while also excelling
in developing innovative medicines management services to increase the
effectiveness of the medication process. This creation of added value, the
strong focus on patients and the commitment to supply medication at low cost for
the benefit of payors and patients make the Group an important strategic partner
for all healthcare stakeholders.

Zur Rose Group is headquartered in Frauenfeld, from where it also serves the
Swiss market. In Germany and Austria, the Group operates through subsidiaries in
Heerlen (Netherlands) and Halle an der Saale (Germany). Furthermore, it holds a
majority interest in BlueCare in Winterthur, the leading provider of networking
systems in the Swiss healthcare market. Employing more than 800 people at its
various locations, Zur Rose Group generated revenue of CHF 880 million in 2016.

Zur Rose Group AG's shares (ticker symbol ROSE, Swiss security no. 4261528, ISIN
CH0042615283) are traded on SIX Swiss Exchange in accordance with the
International Reporting Standard of SIX Swiss Exchange. zurrosegroup.com

--------------------------------------------------------------------------------
End of Corporate News
--------------------------------------------------------------------------------

Language: English

Company:  Zur Rose Group AG

          Walzmühlestrasse 60

          8500 Frauenfeld

          Switzerland

Phone:    +41 52 724 08 14

Internet: www.zurrosegroup.com

ISIN:     CH0199729366, CH0042615283

Listed:   SIX Swiss Exchange



 

End of News EQS Group News Service

--------------------------------------------------------------------------------

640351  29.12.2017